©Atypique
Keurig Dr Pepper (KDP) has signed a definitive agreement to acquire non-alcoholic, ready-to-drink cocktail brand, Atypique, from Station Agro-Biotech.
Atypique provides a range of ready-to-drink cocktails, including margaritas, gin and tonics, and mojitos. The acquisition will complement KDP’s existing ready-to-drink alcohol portfolio and non-alcoholic business in Canada.
The agreement includes a multi-year collaboration between KDP and Quebec-based Station Agro-Biotech to expand Atypique’s reach.
The partnership will combine Station Agro-Biotech’s research and development expertise in the alcoholic and non-alcoholic beverage sector with KDP’s sales and distribution network.
Olivier Lemire, president of Keurig Dr Pepper Canada, said: “We are excited to add this new platform to our powerful portfolio in Canada and the global rights to Atypique provides optionality to further expand the brand’s growth potential. Atypique is a great complement to our successful ready-to-drink alcohol portfolio and we look forward to continue innovating around this brand to drive accelerated growth.”
“We were looking for the best way to bring Atypique to the next level. This agreement represents an exceptional opportunity to work with a beverage industry leader and Keurig Dr Pepper will bring market knowledge and strength to the Atypique brand,” added Jonathan Robin, president of Station Agro-Biotech.
The deal is expected to close in early Q4.
© FoodBev Media Ltd 2022
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry. Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial
Your privacy We use small files known as ‘cookies’ to enhance your experience of the FoodBev website and analyse site-traffic. Read about how we use cookies or how you may control them in our updated privacy policy and cookie policy. If you continue to use this site, you consent to our use of cookies. Click the ‘OKAY‘ button at the top right of this panel to accept or click here for more information.